Multiple Organ Failure: Clinical Trials

15 trials for Multiple Organ Failure, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 4 terminated, 2 unknown, 1 not yet recruiting. 15 Phase 2, 4 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 215Completed 7, Terminated 4, Unknown 2, Not yet recruiting 1, Withdrawn 1
Phase 14Completed 1, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 31Completed 1

Follow Multiple Organ Failure: new trials by email Literature Review of Multiple Organ Failure trials Research Report on Multiple Organ Failure

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Point-of-Care AI Assistance and Critical Care Outcomes: A Randomized Trial
Point-of-care large language model decision support (ChatGPT-5) - Critical Illness, Sepsis
Phase 1 / Phase 2Not yet recruitingMetroWest Artificial Intelligence Research Workgroup10002026-01-012025-12-18
TXA127 for the Treatment of Severe COVID-19
TXA127, Placebo - COVID-19
Phase 2CompletedColumbia University222021-02-102022-07-27
Red Cell Rejuvenation for the Attenuation of Transfusion Associated Organ Injury in Cardiac Surgery
rejuvesol Solution, Standard Care - Organ Failure, Multiple, Inflammation
Phase 2WithdrawnUniversity of Leicester2020-12-012021-04-29
Clinical Use of Stem Cells for the Treatment of Covid-19
MSC Treatment, Saline Control - Covid19, Pneumonia
Phase 1 / Phase 2CompletedSBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi302020-04-012021-05-25
Early Metabolic Resuscitation for Septic Shock
Best Practice, early metabolic resuscitation - Multiple Organ Failure, Septic Shock
Phase 2TerminatedM.D. Anderson Cancer Center22019-10-042024-10-29
Infusion of Prostacyclin vs Placebo for 72-hours in Trauma Patients With Haemorrhagic Shock Suffering From Organ Failure
Iloprost, Isotonic saline - Multi Organ Failure
Phase 2CompletedPär Johansson2282019-05-222024-05-08
The Val-CARD Trial
Sodium Valproate - Cardiac Valve Disease, Coronary Artery Disease
Phase 1 / Phase 2TerminatedUniversity of Leicester452018-11-062026-08-17
Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
Eculizumab - Thrombotic Microangiopathies, Atypical Hemolytic Uremic Syndrome
Phase 2CompletedChildren's Hospital Medical Center, Cincinnati232018-08-032023-09-21
Efficacy and Safety of FP-1201-lyo (Interferon Beta-1a) in Prevention of Multi-Organ Failure on Patients After Open Surgery for a RAAA
Interferon Beta-1A, Placebo - Preventive Medicine, Multi Organ Failure
Phase 2TerminatedFaron Pharmaceuticals Ltd402017-02-182021-01-14
Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148
LB1148, Placebo - Septic Shock
Phase 2TerminatedLeading BioSciences, Inc82015-04-012020-06-01
Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
Menstrual blood stem cells - Acute Lung Injury, Acute Respiratory Distress Syndrome (ARDS)
Phase 1 / Phase 2UnknownS-Evans Biosciences Co., Ltd.202014-03-012014-03-24
Supplemental Parenteral Nutrition in Critically Ill Adults: A Pilot Randomised Controlled Trial
Supplemental PN, Standard Care - Multiple Organ Failure, Critical Illness
Phase 2 / Phase 3CompletedAustralian and New Zealand Intensive Care Research Centre1002014-02-012016-08-02
Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine
ivabradine - Multiple Organ Dysfunction Syndrome
Phase 2UnknownMartin-Luther-Universität Halle-Wittenberg702010-05-012010-09-08
Intrapleural Methylprednisolone Injection for Multiple Organ Failure With Acute Respiratory Distress Syndrome
conventional ECMO with intravenous steroid, solumedrol - Acute Respiratory Distress Syndrome (ARDS), Multiple Organ Failure
Phase 2CompletedNational Taiwan University Hospital292005-06-012011-08-26
Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis
Alkaline Phosphatase, Placebo - Sepsis, Multiple Organ Dysfunction Syndrome
Phase 2CompletedAM-Pharma372004-09-012012-04-02

Narrower conditions

Sepsis (6)  ·  Acute Kidney Injury (2)  ·  COVID-19 (2)  ·  Critical Illness (2)  ·  Respiratory Distress Syndrome (2)  ·  Shock (2)  ·  Shock, Septic (2)  ·  Acute Lung Injury (1)  ·  Atypical Hemolytic Uremic Syndrome (1)  ·  Confusion (1)  ·  Coronary Artery Disease (1)  ·  Coronavirus Infections (1)  ·  Heart Valve Diseases (1)  ·  Hyperlactatemia (1)

Broader conditions

Pathologic Processes (15)  ·  Pathological Conditions, Signs and Symptoms (15)  ·  Shock (13)  ·  Infections (7)  ·  Inflammation (5)  ·  Systemic Inflammatory Response Syndrome (5)  ·  Lung Diseases (4)  ·  Respiratory Tract Diseases (4)  ·  Female Urogenital Diseases (3)  ·  Female Urogenital Diseases and Pregnancy Complications (3)  ·  Kidney Diseases (3)  ·  Male Urogenital Diseases (3)  ·  Urogenital Diseases (3)  ·  Urologic Diseases (3)  ·  Cardiovascular Diseases (2)

Interventions

Standard of Care (3)  ·  Sodium Chloride (2)  ·  2-(3',4'-dihydroxyphenyl-1-azo)benzimidazole (1)  ·  Alkaline Phosphatase (1)  ·  Dietary Supplements (1)  ·  Drugs, Investigational (1)  ·  Glucose (1)  ·  Iloprost (1)  ·  Interferon beta-1a (1)  ·  Ivabradine (1)  ·  Methods (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Parenteral Nutrition (1)  ·  Practice Guidelines as Topic (1)  ·  Proteins (1)

Sponsors

University of Leicester (2)  ·  AM-Pharma (1)  ·  Australian and New Zealand Intensive Care Research Centre (1)  ·  Children's Hospital Medical Center, Cincinnati (1)  ·  Columbia University (1)  ·  Faron Pharmaceuticals Ltd (1)  ·  Leading BioSciences, Inc (1)  ·  M.D. Anderson Cancer Center (1)  ·  Martin-Luther-Universität Halle-Wittenberg (1)  ·  MetroWest Artificial Intelligence Research Workgroup (1)  ·  National Taiwan University Hospital (1)  ·  Pär Johansson (1)  ·  S-Evans Biosciences Co., Ltd. (1)  ·  SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi (1)

Countries

United States (5)  ·  United Kingdom (2)  ·  Australia (1)  ·  Belgium (1)  ·  Canada (1)  ·  China (1)  ·  Denmark (1)  ·  Estonia (1)  ·  Finland (1)  ·  Germany (1)  ·  Lithuania (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Norway (1)  ·  Taiwan (1)

Top investigators

Bart Wuurman, M.Sc. (1)  ·  Charlie Xiang, Doctor (1)  ·  Erdal Karaoz, Prof.Dr. (1)  ·  Eric Silverman, M.D. (1)  ·  Gavin J Murphy, Prof (1)  ·  Gavin Murphy, MD (1)  ·  Gokhan T Adas, Prof.Dr. (1)  ·  Harri Hakovirta, MD (1)  ·  Henning Ebelt, MD (1)  ·  Jeanine D'Armiento, MD, PhD (1)  ·  Joseph L. Nates, MBA,MD (1)  ·  Karl Werdan, MD, Professor (1)  ·  Maarit Venermo, MD (1)  ·  Marius Roman, MD (1)

Results publications

PMID 19048243, PMID 19114895, PMID 21638157, PMID 26703919, PMID 29361959, PMID 33393084, PMID 35115574, PMID 35902867, PMID 37946262

NIH funding

2014 (1), 2018 (1), 2019 (1), P30CA016672 (1)